Efficacy population: Cryptococcal CFU (Log10) at Weeks 0 and 2.
All p-values are calculated using the Kruskal-Wallis test for differences across the four treatment arms.The Kaplan-Meier proportion for mortality (90% CI) in the efficacy population at 10 and 24 weeks for AMB was 17% (10, 29) and 24% (15, 37), compared to 20% (12, 32) and 30% (20, 43) for 1600mg, and 33% (23, 46) and 38% (27, 51) for 2000mg FCZ (